|
| KINASE INHIBITORS 激酶抑制劑 |
訂購(gòu)電話：021-34053660 |
| |
|
|
|
|
| CAS |
產(chǎn)品名字 |
分子量 |
溶劑 |
靶點(diǎn) |
| 167869-21-8 |
PD-98059 |
267.3 |
DMSO |
MEK |
| 109511-58-2 |
U-0126 |
380.5 |
DMSO |
MEK |
| 152121-47-6 |
SB-203580 |
377.4 |
DMSO |
p38 MAPK |
| 84477-87-2 |
H-7 |
364.3 |
DMSO |
PKA, PKG, MLCK, and PKC. |
| 84468-17-7 |
H-9 |
324.3 |
DMSO |
PKA, PKG, MLCK, and PKC. |
| 62996-74-1 |
星形孢菌素 |
466.5 |
DMSO |
Pan-specific |
| 133550-35-5 |
AG-494 |
280.3 |
DMSO |
EGFRK, PDGFRK |
| |
AG-825 |
397.5 |
DMSO |
HER1-2 |
| 125697-92-9 |
Lavendustin A |
381.4 |
DMSO |
EGFRK |
| 136831-49-7 |
RG-14620 |
274.1 |
DMSO |
EGFRK |
| 118409-57-7 |
Tyrphostin 23 |
186.1 |
DMSO |
EGFRK |
| 118409-58-8 |
Tyrphostin 25 |
202.1 |
DMSO |
EGFRK |
| 122520-85-8 |
Tyrphostin 46 |
204.2 |
DMSO |
EGFRK, PDGFRK |
| 122520-86-9 |
Tyrphostin 47 |
220.2 |
DMSO |
EGFRK |
| 122520-90-5 |
Tyrphostin 51 |
268.2 |
DMSO |
EGFRK |
| 2826-26-8 |
Tyrphostin 1 |
184.2 |
DMSO |
Negative control for tyrosine kinase inhibitors. |
| 116313-73-6 |
Tyrphostin AG 1288 |
231.2 |
DMSO |
Tyrosine kinases |
| 63177-57-1 |
Tyrphostin AG 1478 |
315.8 |
DMSO |
EGFRK |
| 71897-07-9 |
Tyrphostin AG 1295 |
234.3 |
DMSO |
Tyrosine kinases |
| 10537-47-0 |
Tyrphostin 9 |
282.4 |
DMSO |
PDGFRK |
| |
HNMPA |
238.2 |
DMSO |
IRK |
| 120685-11-2 |
PKC-412 |
570.6 |
DMSO |
PKC inhibitor |
| 10083-24-6 |
Piceatannol |
244.3 |
DMSO |
Syk |
| 172889-26-8 |
PP1 |
281.4 |
DMSO |
Src family |
| 133550-35-3 |
AG-490 |
294.3 |
DMSO |
JAK-2 |
| |
AG-126 |
215.2 |
DMSO |
IRAK |
| |
AG-370 |
259.3 |
DMSO |
PDGFRK |
| |
AG-879 |
316.5 |
DMSO |
NGFRK |
| 154447-36-6 |
LY 294002 |
307.4 |
DMSO |
PI 3-K |
| 19545-26-7 |
Wortmannin |
428.4 |
DMSO |
PI 3-K |
| 133052-90-1 |
GF 109203X |
412.5 |
DMSO |
PKC |
| 548-04-9 |
Hypericin |
504.4 |
DMSO |
PKC |
| 138489-18-6 |
Ro 31-8220 |
553.7 |
DMSO |
PKC |
| 123-78-4 |
Sphingosine |
299.5 |
DMSO |
PKC |
| 127243-85-0 |
H-89 |
519.2 |
DMSO |
PKA |
| 84478-11-5 |
H-8 |
338.3 |
DMSO |
PKA, PKG |
| 91742-10-8 |
HA-1004 |
329.8 |
DMSO |
PKA, PKG |
| 103745-39-7 |
HA-1077 |
327.8 |
DMSO |
PKA, PKG |
| |
HDBA |
275.3 |
DMSO |
EGFRK, CaMK II |
| 127191-97-3 |
KN-62 |
721.9 |
DMSO |
CaMK II |
| |
KN-93 |
501 |
DMSO |
CaMK II |
| 109376-83-2 |
ML-7 |
452.7 |
DMSO |
MLCK |
| 105637-50-1 |
ML-9 |
361.3 |
DMSO |
MLCK |
| 452-06-2 |
2-Aminopurine |
135.1 |
DMSO |
p58 PITSLRE beta1 |
| 158982-15-1 |
N9-Isopropyl-olomoucine |
326.4 |
DMSO |
CDK |
| 101622-51-9 |
Olomoucine |
298.3 |
DMSO |
CDK |
| 101622-50-8 |
iso-Olomoucine |
298.4 |
DMSO |
Negative control for olomoucine. |
| 186692-46-6 |
Roscovitine |
354.5 |
DMSO |
CDK |
| 24386-93-4 |
5-Iodotubercidin |
392.2 |
DMSO |
ERK2, adenosine kinase, CK1, CK2, |
| 62004-35-7 |
LFM-A13 |
360 |
DMSO |
BTK |
| 152121-30-7 |
SB-202190 |
331.3 |
DMSO |
p38 MAPK |
| 172889-27-9 |
PP2 |
301.8 |
DMSO |
Src family |
| 208260-29-1 |
ZM 336372 |
389.4 |
DMSO |
cRAF |
| 5812-07-7 |
SU 4312 |
264.3 |
DMSO |
Flk1 |
| 146535-11-7 |
AG-1296 |
266.3 |
DMSO |
PDGFRK |
| 220904-83-6 |
GW 5074 |
520.9 |
DMSO |
cRAF |
| 6865-14-1 |
Palmitoyl-DL-carnitine Cl |
436.1 |
DMSO |
PKC |
| 82-08-6 |
Rottlerin |
516.6 |
DMSO |
PKC delta |
| 446-72-0 |
Genistein |
270.2 |
DMSO |
Tyrosine Kinases |
| 486-66-8 |
Daidzein |
254.2 |
DMSO |
Negative control for Genistein. |
| 63177-57-1 |
Erbstatin analog |
194 |
DMSO |
EGFRK |
| 6151-25-3 |
Quercetin dihydrate |
338.3 |
DMSO |
PI 3-K |
| |
SU1498 |
390.5 |
DMSO |
Flk1 |
| 4452-06-6 |
ZM 449829 |
182.2 |
DMSO |
JAK-3 |
| 195462-67-7 |
BAY 11-7082 |
207.3 |
DMSO |
IKK pathway |
| 53-85-0 |
DRB |
319.1 |
DMSO |
CK II |
| |
HBDDE |
338.4 |
DMSO |
PKC alpha, PKC gamma |
| 129-56-6 |
SP 600125 |
220.2 |
DMSO |
JNK |
| 479-41-4 |
Indirubin |
262 |
DMSO |
GSK-3beta, CDK5 |
| 160807-49-8 |
Indirubin-3'-monoxime |
277.3 |
DMSO |
GSK-3beta |
| 146986-50-7 |
Y-27632 |
338.3 |
DMSO |
ROCK |
| 142273-20-9 |
Kenpaullone |
327.2 |
DMSO |
GSK-3beta |
| 121-40-4 |
Terreic acid |
154.1 |
DMSO |
BTK |
| 35943-35-2 |
Triciribine |
320.3 |
DMSO |
Akt signaling pathway |
| |
BML-257 |
326.4 |
DMSO |
Akt |
| |
SC-514 |
224.3 |
DMSO |
IKK2 |
| |
BML-259 |
260.4 |
DMSO |
Cdk5/p25 |
| 520-36-5 |
Apigenin |
270.2 |
DMSO |
CK-II |
| |
BML-265 (Erlotinib analog) |
305.4 |
DMSO |
EGFRK |
| 53123-88-9 |
Rapamycin |
914.2 |
DMSO |
mTOR |
|
|